Specific protein signatures can predict Crohn's disease and ulcerative colitis, enabling early intervention in IBD. The study identified 34 proteins for Crohn's disease and 45 for ulcerative colitis, ...

A study lead by researchers from Mayo Clinic suggests remission from Crohn’s disease may be more likely if patients receive biologic therapy combined with immune-suppressing drugs first instead of ...

Stelara is a biologic medicine used to treat moderate to severe Crohn’s disease and ulcerative colitis. Crohn’s disease and ulcerative colitis are inflammatory bowel diseases that cause inflammation ...

ROCHESTER, Minnesota — Inflammatory bowel disease, or IBD, is an umbrella term for a group of chronic conditions that cause inflammation and swelling in the digestive tract. It primarily includes two ...

Ulcerative colitis and Crohn’s disease are types of inflammatory bowel disease (IBD) that cause irritation and inflammation in the gastrointestinal tract (GI tract). The immune system attacks the GI ...

Picture this common clinical scenario: A patient has chronic diarrhea, abdominal pain, and weight loss. Blood and stool tests point to inflammatory bowel disease (IBD). But which one -- Crohn's ...

Over the past 15 years, treatment options for ulcerative colitis (UC) have expanded quite a bit. Among the most common options is a class of drugs called biologics. Biologics are derived from natural ...